Braun Aura 9 (6042)
Cyden Limited · Decision date Sep 25, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 25 September 2026 for Braun Aura 9 (6042), submitted by Cyden Limited of Swansea, GB, under 510(k) number K261977. The application was received on 12 June 2026. The device falls under classification product code OHT, light based over-the-counter hair removal, regulation number 878.4810, with the General & Plastic Surgery medical specialty and review panel.
A SESE decision means the FDA cleared the submission as substantially equivalent to a legally marketed predicate device; it is not a premarket approval. The public record lists a special summary, no third-party review, no combination product status and no authorized predetermined change control plan. The page does not describe the specific device components, the predicate device, or the basis for the equivalence finding, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261977
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Cyden Limited
- Product code
- OHT
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light Based Over-The-Counter Hair Removal.
- Applicant
- Cyden Limited
- Product code
- OHT
- FDA device class
- 2
FDA decision timeline
K261977 received
Application receipt date recorded by FDA.
K261977 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OHT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ShenZhen Qiyue Trading Co., Ltd. | 510(k) clearance | Nov 3, 2026 | FDA | |
| Shenzhen Jianchao Intelligent Technology Co., Ltd. | 510(k) clearance | Oct 9, 2026 | FDA | |
Braun Aura 7 (6041)K261975 | Cyden Limited | 510(k) clearance | Sep 30, 2026 | FDA |
| ONE BEAUTY Technology Co., Ltd. | 510(k) clearance | Sep 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cyden Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Swansea
Sources and methodology
- Original FDA record: K261977
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

